68Ga-FAPI PET/CT在小儿神经母细胞瘤评估中的增量诊断价值
本文报告一名16岁经手术治疗的神经母细胞瘤女孩复发再评估病例。18F-FDG PET/CT显示腹部病灶摄取轻微、肝低密度灶无摄取、无骨受累;68Ga-FAPI PET/CT显示腹部肿瘤异质性中至高度摄取,并发现额外肝及骨转移,从而准确再分期并影响治疗决策。
要点
- FDG PET/CT可能低估神经母细胞瘤病灶范围。
- FAPI PET/CT可检出FDG阴性的肝及骨转移。
- FAPI PET/CT有助于精准再分期并影响治疗决策。
核心结论
- 当FDG PET/CT低估病变范围时,FAPI PET/CT具有增量诊断价值。
研究设计与样本
- 单例病例报告,报告一名16岁经手术治疗的神经母细胞瘤女孩复发再评估。
主要发现
- 18F-FDG PET/CT显示腹部病灶摄取轻微、略低于肝活性,肝低密度灶无FDG摄取初判良性,无骨受累。
- 68Ga-FAPI PET/CT显示腹部肿瘤异质性中至高度摄取,并发现额外肝及骨转移。
临床怎么用
- 在FDG PET/CT低估病变范围时,可考虑FAPI PET/CT以辅助准确再分期并影响治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neuroblastoma staging typically involves 18 F-FDG PET/CT or 123 I-MIBG scintigraphy, although their sensitivity may be limited. We present a 16-year-old girl with previously operated neuroblastoma who was reevaluated for recurrence. 18 F-FDG PET/CT showed minimal uptake in the abdominal lesion, slightly lower than liver activity, a hypodense hepatic lesion without FDG uptake initially considered benign, and no osseous involvement. In contrast, 68 Ga-FAPI PET/CT demonstrated heterogeneous moderate-to-intense uptake in the abdominal tumor, revealing additional hepatic and osseous metastases, which enabled accurate restaging and influenced management. This case highlights the incremental diagnostic value of FAPI PET/CT when FDG PET/CT underestimates disease extent.
引用
- Gungor S. Incremental Diagnostic Value of 68 Ga-FAPI PET/CT in Evaluating Pediatric Neuroblastoma. Clin Nucl Med. 2026. PMID: 41650164. doi:10.1097/RLU.0000000000006356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。